Robert Ford

5.6k total citations · 2 hit papers
20 papers, 3.7k citations indexed

About

Robert Ford is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Robert Ford has authored 20 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Robert Ford's work include Radiomics and Machine Learning in Medical Imaging (8 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Genomics and Diagnostics (4 papers). Robert Ford is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (8 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Genomics and Diagnostics (4 papers). Robert Ford collaborates with scholars based in United States, Canada and United Kingdom. Robert Ford's co-authors include Lalitha Shankar, Jan Bogaerts, Lawrence H. Schwartz, Janet Dancey, Patrick Therasse, Elisabeth G.E. de Vries, Saskia Litière, Sumithra J. Mandrekar, Nancy U. Lin and Lesley Seymour and has published in prestigious journals such as Journal of Clinical Oncology, Brain and The Lancet Oncology.

In The Last Decade

Robert Ford

19 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

2017 1.5k citations Lesley Seymour, Jan Bogaerts et al. The Lancet Oncology profile →
RECIST 1.1—Update and clarification: From the RECIST committee

2016 1.2k citations Lawrence H. Schwartz, Saskia Litière et al. European Journal of Cancer profile →

Peers

Countries citing papers authored by Robert Ford

Since Specialization

Citations

This map shows the geographic impact of Robert Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Ford more than expected).

Fields of papers citing papers by Robert Ford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Ford. The network helps show where Robert Ford may publish in the future.

Co-authorship network of co-authors of Robert Ford

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Ford. A scholar is included among the top collaborators of Robert Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Ford. Robert Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Radiologists and Clinical Trials: Part 2: Practical Statistical Methods for Understanding and Monitoring Independent Reader Performance 2021 ·Therapeutic Innovation & Regulatory Science ·David Raunig, Annette M. Schmid, Colin G. Miller, Richard C. Walovitch, Michael O’Connor, (unknown), (unknown), Michael O’Neal, (unknown), Robert Ford	6
2	Radiologists and Clinical Trials: Part 1 The Truth About Reader Disagreements 2021 ·Therapeutic Innovation & Regulatory Science ·Annette M. Schmid, David Raunig, Colin G. Miller, Richard C. Walovitch, (unknown), Michael O’Connor, (unknown), Josy Breuer, (unknown), Robert Ford	19
3	RECIST 1.1 for Response Evaluation Apply Not Only to Chemotherapy-Treated Patients But Also to Targeted Cancer Agents: A Pooled Database Analysis 2019 ·Journal of Clinical Oncology ·Saskia Litière, (unknown), Elisabeth G.E. de Vries, Jan Bogaerts, Alice P. Chen, Janet Dancey, Robert Ford, Stephen J. Gwyther, Otto S. Hoekstra, Erich P. Huang, Nancy U. Lin, Yan Liu, Sumithra J. Mandrekar, Lawrence H. Schwartz, Lalitha Shankar, Patrick Therasse, Lesley Seymour, (unknown)	46
4	iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics breakdown → 2017 ·The Lancet Oncology ·Lesley Seymour, Jan Bogaerts, Andrea Perrone, Robert Ford, Lawrence H. Schwartz, Sumithra J. Mandrekar, Nancy U. Lin, Saskia Litière, Janet Dancey, Alice Chen, F. Stephen Hodi, Patrick Therasse, Otto S. Hoekstra, Lalitha Shankar, Jedd D. Wolchok, Marcus Ballinger, Caroline Caramella, Elisabeth G.E. de Vries	1528
5	Validation of RECIST 1.1 for use with cytotoxic agents and targeted cancer agents (TCA): Results of a RECIST Working Group analysis of a 50 clinical trials pooled individual patient database. 2017 ·Journal of Clinical Oncology ·Saskia Litière, (unknown), Elisabeth G.E. de Vries, Jan Bogaerts, Alice P. Chen, Janet Dancey, Robert Ford, (unknown), Otto S. Hoekstra, Erich P. Huang, Nancy U. Lin, Yan Liu, Sumithra J. Mandrekar, Lawrence H. Schwartz, Lalitha Shankar, Patrick Therasse, Lesley Seymour, (unknown)	6
6	RECIST 1.1—Update and clarification: From the RECIST committee breakdown → 2016 ·European Journal of Cancer ·Lawrence H. Schwartz, Saskia Litière, Elisabeth G.E. de Vries, Robert Ford, Stephen J. Gwyther, Sumithra J. Mandrekar, Lalitha Shankar, Jan Bogaerts, Alice P. Chen, Janet Dancey, Wendy Hayes, F. Stephen Hodi, Otto S. Hoekstra, Erich P. Huang, Nancy U. Lin, Yan Liu, Patrick Therasse, Jedd D. Wolchok, Lesley Seymour	1206
7	RECIST 1.1 – Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group 2016 ·European Journal of Cancer ·Lawrence H. Schwartz, Lesley Seymour, Saskia Litière, Robert Ford, Stephen J. Gwyther, Sumithra J. Mandrekar, Lalitha Shankar, Jan Bogaerts, Alice P. Chen, Janet Dancey, Wendy Hayes, F. Stephen Hodi, Otto S. Hoekstra, Erich P. Huang, Nancy U. Lin, Yi Yan, Patrick Therasse, Jedd D. Wolchok, Elisabeth G.E. de Vries	221
8	Investigator and independent review committee exploratory assessment and verification of tumor response in a non-Hodgkin lymphoma study 2016 ·Leukemia & lymphoma ·Robert Ford, (unknown), (unknown), (unknown), Michael O’Neal, Brad S. Kahl, Ling Chen, Mihaela Munteanu, Bruce D. Cheson	2
9	Monitoring Reader Metrics in Blinded Independent Central Review of Oncology Studies 2015 ·Journal of Clinical Trials ·(unknown), Robert Ford	6
10	Comparison of 1D, 2D, and 3D Nodule Sizing Methods by Radiologists for Spherical and Complex Nodules on Thoracic CT Phantom Images 2013 ·Academic Radiology ·Nicholas Petrick, (unknown), David Clunie, (unknown), Robert Ford, Rongping Zeng, Marios A. Gavrielides, Michael F. McNitt‐Gray, Zhenzhen Lu, Charles Fenimore, Binsheng Zhao, Andrew J. Buckler	37
11	Recommendations for the assessment of progression in randomised cancer treatment trials 2008 ·European Journal of Cancer ·Janet Dancey, Lori E. Dodd, Robert Ford, Richard Kaplan, Margaret Mooney, Larry Rubinstein, Lawrence H. Schwartz, Lalitha Shankar, P. Therasse	87
12	Individual patient data analysis to assess modifications to the RECIST criteria 2008 ·European Journal of Cancer ·Jan Bogaerts, Robert Ford, Daniel J. Sargent, Lawrence H. Schwartz, Larry Rubinstein, Denis Lacombe, Elizabeth A. Eisenhauer, Jaap Verweij, Patrick Therasse	157
13	Evaluation of lymph nodes with RECIST 1.1 2008 ·European Journal of Cancer ·Lawrence H. Schwartz, Jan Bogaerts, Robert Ford, Lalitha Shankar, P. Therasse, Stephen J. Gwyther, E. Eisenhauer	206
14	Lessons learned from independent central review 2008 ·European Journal of Cancer ·Robert Ford, Lawrence H. Schwartz, Janet Dancey, Lori E. Dodd, E. Eisenhauer, Stephen J. Gwyther, Larry Rubinstein, Daniel J. Sargent, Lalitha Shankar, P. Therasse, Jaap Verweij	82
15	Test of partners in flight effective detection distance for Cerulean Warbler / Evaluación de distancia efectiva de detección para la Reinita Cerúlea (Dendroica cerulea) seleccionada por Compañeros En Vuelo 2008 ·Paul B. Hamel, (unknown), (unknown), Robert Ford	1
16	32 INVITED New response evaluation criteria in solid tumors: revised RECIST guideline version 1.1 2008 ·European Journal of Cancer Supplements ·E. Eisenhauer, P. Therasse, J. Bogaerts, Lawrence H. Schwartz, (unknown), Robert Ford, Janet Dancey, Susan G. Arbuck, Stephen J. Gwyther, Margaret Mooney, (unknown), Lalitha Shankar, Richard Kaplan, Denis Lacombe, Jaap Verweij	15
17	Report of Task Force II: Best Practices in the Use of Medical Imaging Techniques in Clinical Trials 2008 ·Drug Information Journal ·Robert Ford, P. David Mozley	2
18	Evaluation of number of target lesions to analyze in time to progression by RECIST 2007 ·Journal of Clinical Oncology ·Mithat Gönen, Lawrence H. Schwartz, Robert Ford	0
19	An inhibitor of thymic hormone activity in serum from patients with lymphoblastic leukemia 1980 ·The American Journal of Medicine ·J.J. Twomey, Verna M. Lewis, Robert Ford, Gideon Goldstein	6
20	ECHOENCEPHALOGRAPHY—THE MEASUREMENT OF THE POSITION OF MID-LINE STRUCTURES IN THE SKULL WITH HIGH FREQUENCY PULSED ULTRASOUND 1963 ·Brain ·Robert Ford, J. Ambrose	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact